Recro Pharma Inc. (REPH): Largest Shareholder Broadfin Capital Buys Even More Shares

Page 8 of 8

Page 8 of 8 – SEC Filing
Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13D/A, dated August 17, 2016, relating to the Common Stock par value $0.01 of Recro Pharma, Inc. shall be filed on behalf of the undersigned.
August 17, 2016
(Date)
BROADFIN CAPITAL, LLC
By:
/s/ Kevin Kotler
Kevin Kotler, Managing Member
KEVIN KOTLER
/s/ Kevin Kotler
BROADFIN HEALTHCARE MASTER FUND, LTD.
By:
/s/ Kevin Kotler
Kevin Kotler, Director
SK 25125 0001 7237800 v2

Follow Societal Cdmo Inc. (NASDAQ:SCTL)

Page 8 of 8